Cited by 484Antifungal resistance and susceptibilityBacterial Identification and Susceptibility TestingYeasts and Rust Fungi Studies

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Open access

Pfaller, M. A., Diekema, D. J.·2012·Journal of Clinical Microbiology

DOI 10.1128/jcm.00937-12PMC PMC3421803

Open this paper in CoChat — free account Open PDF

Abstract

Antifungal susceptibility testing of Candida has been standardized and refined and now may play a useful role in managing Candida infections. Important new developments include validation of 24-h reading times for all antifungal agents and the establishment of species-specific epidemiological cutoff values (ECVs) for the systemically active antifungal agents and both common and uncommon species of Candida . The clinical breakpoints (CBPs) for fluconazole, voriconazole, and the echinocandins have been revised to provide species-specific interpretive criteria for the six most common species. The revised CBPs not only are predictive of clinical outcome but also provide a more sensitive means of identifying those strains with acquired or mutational resistance mechanisms. This brief review serves as an update on the new developments in the antifungal susceptibility testing of Candida spp. using Clinical and Laboratory Standards Institute (CLSI) broth microdilution (BMD) methods.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/jcm.00937-12

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,811
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study.
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171
A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Candida and candidiasis.
Calderone, R. (2012) · ASM Press eBooks · Cited by 912
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Self-citation
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Self-citation

Show all 105 references

Research works printed but not linked: 1

PfallerMA DiekemaDJ. 2007. Azole antifungal drug cross-resistance: mechanisms, epidemiology, and clinical significance. J. Invasive Fungal Infect. 1:74–92.

Sorted by citations

Items 301–400 of 481

Two missense mutations, E123Q and K151E, identified in the ERG11 allele of an azole-resistant isolate of Candida kefyr recovered from a stem cell transplant patient for acute myeloid leukemia
Couzigou, C., Gabriel, F., Biteau, N., Fitton‐Ouhabi, V., Noël, T., & Accoceberry, I. (2014) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2014.04.002 · Cited by 10
Multilocus sequence typing indicates diverse origins of invasive Candida tropicalis isolates in China
Fan, X., Xiao, M., Wang, H., Zhang, L., Kong, F., Lü, J., Hu, Z., Kang, M., & Xu, Y. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20142048 · Cited by 10
Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry azole susceptibility assessment in Candida and Aspergillus species
Giordano, A. L. P. L., Pontes, L., Beraquet, C. A. G., Lyra, L., & Schreiber, A. Z. (2023) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760220213 · Cited by 9
In Vitro Assessment of Fluconazole and Cyclosporine A Antifungal Activities: A Promising Drug Combination Against Different Candida Species
Cartón, J. D., de la Fuente, I., Sevillano, E., Jauregizar, N., Quindós, G., Eraso, E., & Guridi, A. (2025) · Journal of Fungi · doi:10.3390/jof11020133 · Cited by 9
Expression of ERG11 and efflux pump genes CDR1, CDR2 and SNQ2 in voriconazole susceptible and resistant Candida glabrata strains
Navarro-Rodríguez, P., Martín‐Vicente, A., López‐Fernández, L., Guarro, J., & Capilla, J. (2019) · Medical Mycology · doi:10.1093/mmy/myz014 · Cited by 10
Prevalence and in vitro antifungal susceptibility of commensal yeasts in the external ear canal of cats
Niae, S., Yurayart, C., Thengchaisri, N., & Sattasathuchana, P. (2021) · BMC Veterinary Research · doi:10.1186/s12917-021-02995-7 · Cited by 9
Antifungal Resistance and Genotyping of Clinical Candida parapsilosis Complex in Japan
Khalifa, H. O., Watanabe, A., & Kamei, K. (2023) · Journal of Fungi · doi:10.3390/jof10010004 · Cited by 9
Heteroleptic complexes of antifungal drugs with the silver ion
Giulidori, C., Mosconi, N., Toplikar, B., Vega, M., Williams, P. A. M., Svetaz, L. A., Raimondi, M., & Rizzotto, M. (2016) · Journal of Physical Organic Chemistry · doi:10.1002/poc.3603 · Cited by 9
Breakthrough disseminated Saprochaete capitata infection in a child with acute myeloid leukaemia receiving caspofungin therapy
Purohit, P., Al-Obaid, I., Al‐Oneizi, E., Al‐Hindi, O., Joseph, L., Ahmad, S., & Khan, Z. (2014) · JMM Case Reports · doi:10.1099/jmmcr.0.001750 · Cited by 9
Comparison of the VITEK 2 antifungal susceptibility system with Etest using clinical isolates of Candida species
Alfouzan, W. A., Al-Enezi, T., AlRoomi, E., Vayalil, S., Chandy, R. G., & Khan, Z. U. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.12.002 · Cited by 9
In vitro Antibacterial Activity of an FDA-Approved H+-ATPase Inhibitor, Bedaquiline, Against Streptococcus mutans in Acidic Milieus
Zhang, M., Yu, W., Zhou, S., Zhang, B., Lo, E. C. M., Xu, X., & Zhang, D. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.647611 · Cited by 9
Vulvovaginal candidiasis: Clinical profile, species distribution and antifungal susceptibility pattern
Mariyah, S., Iyer, R. N., Jangam, R. R., & Kesireddy, S. (2022) · Journal of The Academy of Clinical Microbiologists · doi:10.4103/jacm.jacm_24_22 · Cited by 8
Navigating fungal infections and antifungal stewardship: drug resistance, susceptibility testing, therapeutic drug monitoring and future directions
Gupta, A., Mann, A., Ravi, S. P., & Wang, T. (2023) · Italian Journal of Dermatology and Venereology · doi:10.23736/s2784-8671.23.07694-6 · Cited by 8
Molecular identification and antifungal susceptibility profile of rare and emerging yeast species causing onychomycosis
Jabrodini, A., Eghtedarnejad, E., Ghanbarzadeh, A., Motamedi, M., Jafari, M., Kharazi, M., Yazdanpanah, S., & Khodadadi, H. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07197-0 · Cited by 8
Identification of Candida parapsilosis Sensu Lato in Pediatric Patients and Antifungal Susceptibility Testing
Cattana, M. E., Dudiuk, C., Fernández, M. S., Rojas, F. D., Alegre, L., Córdoba, S. B., García‐Effrón, G., & Giusiano, G. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02754-16 · Cited by 8
Synthesis of Pincer type carbene and their Ag(I)-NHC complexes, and their Antimicrobial activities
Türkyılmaz, M., Dönmez, M., & Ateş, M. (2022) · Journal of Sustainable Construction Materials and Technologies · doi:10.47481/jscmt.1117139 · Cited by 8
Compare the physicochemical and biological properties of engineered polymer-functionalized silver nanoparticles against Porphyromonas gingivalis
Zhang, M., & Lo, E. C. M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.985708 · Cited by 8
Comparison of Commercial Methods and the CLSI Broth Microdilution to Determine the Antifungal Susceptibility of Candida parapsilosis Complex Bloodstream Isolates from Three Health Institutions in Rio de Janeiro, Brazil
Figueiredo‐Carvalho, M. H. G., Barbedo, L. S., Oliveira, M. M. E., Brito‐Santos, F., Almeida‐Paes, R., & Zancopé‐Oliveira, R. M. (2014) · Mycopathologia · doi:10.1007/s11046-014-9771-3 · Cited by 8
Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical Isolates.
Mohammadi, R., & Ataei, B. (2016) · PubMed Central · Cited by 8
Genetic diversity of theHwp1gene andHIS3, EF3, CDC3microsatellites and antifungal susceptibility profiles ofCandida albicansisolates from Yaoundé HIV-infected patients
Ngouana, T. K., Drakulovski, P., Krasteva, D., Toghueo, R. M. K., Kouanfack, C., Reynes, J., Delaporte, É., Boyom, F. F., Mallié, M., & Bertout, S. (2016) · Medical Mycology · doi:10.1093/mmy/myw108 · Cited by 8
Promising synergistic activity of fluconazole with bioactive Guttiferone-A and derivatives against non-albicans Candida species
de Carvalho, R. R., Silva, N. C., Cusinato, M., Dias, K. S. T., dos Santos, M. H., Viegas, C., Silva, É. G., & Dias, A. L. T. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.07.006 · Cited by 8
Clinical and microbiological features of candiduria in critically ill adult patients in Shiraz, Iran (2016–2018): deviations from international guidelines and fluconazole therapeutic failure
Arastehfar, A. A., Sadati, S. K., Zareshahrabadi, Z., Fang, W., Pan, W., Asadpour, E., Daneshnia, F., İlkit, M., Boekhout, T., Perlin, D. S., et al. (2020) · Medical Mycology · doi:10.1093/mmy/myaa092 · Cited by 8
Antifungal, phyto, cyto, genotoxic and lipophilic properties of three complexes of sulfadimethoxine (HSDM) with Ag(I). Synthesis and characterization of [Ag3SDM(SCN)2]·H2O and [Ag2(SDM)2o-phenanthroline]·H2O
Mosconi, N., Monti, L., Giulidori, C., Williams, P. A. M., Raimondi, M., Bellú, S. E., & Rizzotto, M. (2020) · Polyhedron · doi:10.1016/j.poly.2020.114965 · Cited by 8
Molecular Characterization of Candida parapsilosis Species Complex in Niches of the Oral Cavity in a Cohort of Patients from Argentina with Different Oral and Dental Clinical Manifestations
Rodríguez, L. E. V. (2016) · Journal of Dental Science and Therapy · doi:10.24218/jdst.2016.05 · Cited by 8
Oral candidal carriage correlates with CD4+ cell count but not with HIV and highly active antiretroviral therapy status
Sah, P., Patel, P., Chandrashekar, C., Devadas, S. M., Ballal, M., Hegde, M., Guddattu, V., Murdoch, C., Sharma, M., & Radhakrishnan, R. A. (2019) · Journal of Investigative and Clinical Dentistry · doi:10.1111/jicd.12438 · Cited by 8
Mycological Profile of Candida tropicalis and its Virulence Factors from Candidemia Patients at A Tertiary Care Facility
Mohanraj, H., Vinodhini, V. M., & Vajravelu, L. K. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.2.27 · Cited by 7
Mechanisms of Drug Resistance in Candida albicans
Sanglard, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_15 · Cited by 7
Candidaemia in a tertiary care academic hospital in Italy. The impact of C. parapsilosis complex on the species distribution and antifungal susceptibility
Ghezzi, M. C., Brunetti, G., Visconti, V. V., Giordano, A., & Raponi, G. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000505 · Cited by 7
In Vitro Azole and Amphotericin B Susceptibilities of Malassezia furfur from Bloodstream Infections Using E-Test and CLSI Broth Microdilution Methods
Rhimi, W., Aneke, C. I., Mosca, A., Otranto, D., & Cafarchia, C. (2020) · Antibiotics · doi:10.3390/antibiotics9060361 · Cited by 7
Investigating the Antagonistic Effect of Indigenous Probiotics on Carbapenem‐Resistant Pseudomonas aeruginosa Strains
Ghiaei, A., Ghasemi, S. M., & Shokri, D. (2023) · BioMed Research International · doi:10.1155/2023/6645657 · Cited by 7
Synthesis, Characterization, and Antibacterial Activity of New Poly(ether‐amide)/Silver Nanocomposites
Faghihi, K., Raeisi, A., Honardoost, E., Shabanian, M., & Mirzakhanian, Z. (2016) · Advances in Polymer Technology · doi:10.1002/adv.21669 · Cited by 7
Oral Yeast Colonization and Fungal Infections in Peritoneal Dialysis Patients: A Pilot Study
Simões‐Silva, L., Silva, S., Santos-Araújo, C., Sousa, J. V., Pestana, M., Araújo, R., Soares‐Silva, I., & Sampaio‐Maia, B. (2017) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2017/4846363 · Cited by 7
Synthesis and biological activity of fibrate-based acyl- and alkyl-phenoxyacetic methyl esters and 1,2-dihydroquinolines
Pucheta, A., Mendieta‐Moctezuma, A., Madrigal-Aguilar, D. A., Hernández‐Benitez, R. I., Romero, L., Garduño‐Siciliano, L., Rugerio-Escalona, C., Cruz, M. D. C., Jiménez, F., Ramírez-Villalva, A., et al. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02496-1 · Cited by 7
Expect the unexpected: fungemia caused by uncommon Candida species in a Turkish University Hospital
Alp, Ş., Gülmez, D., Kardaş, R. C., Karahan, G., Taş, Z., Gürsoy, G., Ayaz, Ç. M., Arıkan-Akdağlı, S., & Akova, M. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04147-5 · Cited by 7
Biological Evaluation and Molecular Docking Study of Euparin and Its Maleic Anhydride and Semicarbazide Derivatives
Zarrinzadeh, G., Tajbakhsh, M., Hosseinzadeh, R., Khalilzadeh, M. A., & Hosseinzadeh, M. (2021) · Polycyclic aromatic compounds · doi:10.1080/10406638.2021.2015405 · Cited by 7
Antifungal Susceptibility of Oral Candida Isolates from Mother-Infant Dyads to Nystatin, Fluconazole, and Caspofungin
Alkhars, N., Gaca, A. O., Zeng, Y., Jallad, N. A., Rustchenko, E. P., Wu, T. T., Eliav, E., & Xiao, J. (2023) · Journal of Fungi · doi:10.3390/jof9050580 · Cited by 7
Post-transcriptional control of antifungal resistance in human fungal pathogens
Sharma, C., & Kadosh, D. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2080527 · Cited by 6
Microevolution of Candida glabrata (Nakaseomyces glabrata) during an infection
López-Marmolejo, A. L., Hernández-Chávez, M. J., Gutiérrez‐Escobedo, G., Herrera-Basurto, M. S., Mora-Montes, H. M., Peñas, A. D. L., & Castaño, I. (2024) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2024.103891 · Cited by 6
Molecular epidemiology and antifungal susceptibility of dermatophytes and Candida isolates in superficial fungal infections at a grade A tertiary hospital in Northern China
Zhang, R., Song, Z., Su, X., Ting, L., Xu, J., He, X., Yuanwen, Y., Chang, B., & Kang, Y. (2024) · Medical Mycology · doi:10.1093/mmy/myae087 · Cited by 6
Increase of Non-albicans Candida Species and Their Antifungal Susceptibility in Intensive Care Unit Patients (Mexico)
Calvillo‐Medina, R. P., Mejía-Romero, R. A., Martínez‐Neria, M., Olalde-Elias, J. J., & Domínguez-Márquez, F. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-022-01148-7 · Cited by 6
Evaluation of virulence factors and azole resistance mechanisms of Candida tropicalis isolates from head and neck cancer patients with OPC
Jahanshiri, Z., Manifar, S., & Hatami, F. (2023) · Iranian Journal of Microbiology · doi:10.18502/ijm.v15i1.11933 · Cited by 6
Design, synthesis, biological evaluation, and molecular docking of euparin and 2‑hydroxy acetophenone hydrazone derivatives as potential AchE inhibitors
Zarrinzadeh, G., Tajbakhsh, M., Hosseinzadeh, R., Ghanbarimasir, Z., Roudbary, M., Mohseni, M., & Nadri, H. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136284 · Cited by 6
The role of fruits as reservoirs for resistant and virulent strains of opportunistic yeasts
Glushakova, A. M., Качалкин, А. В., & Rodionova, E. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03758-2 · Cited by 6
Molecular diagnosis, phylogenetic analysis, and antifungal susceptibility profiles of Candida species isolated from neutropenic oncological patients
Hassanpour, P., Spotin, A., Morovati, H., Maleki, L. A., Raeisi, M., Rezaee, M. A., Hasani, A., Aghebati‐Maleki, A., Abdollahzadeh, H., & Nami, S. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08774-z · Cited by 6
13 Diagnostics of Fungal Infections
Willinger, B., Kienzl, D., & Kurzai, O. (2013) · Springer eBooks · doi:10.1007/978-3-642-39432-4_13 · Cited by 6
Comparison of anti-Candida albicans activities of halogenomethylsulfonyl derivatives
Bondaryk, M., Ochal, Z., & Staniszewska, M. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1258-8 · Cited by 6
Antifungal Susceptibility Testing of Ascomycetous Yeasts Isolated from Animals
Álvarez‐Pérez, S., García, M. E., Peláez, T., Martínez‐Nevado, E., & Blanco, J. L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00306-16 · Cited by 6
Don’t mess with the machine — evaluation of fluconazole susceptibility testing for Candida glabrata using the new VITEK2 AST-YS08 card following species modification
Korem, M., Geffen, Y., & Amit, S. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.114896 · Cited by 6
Caspofungin Effects on Electrocardiogram of Mice: An Evaluation of Cardiac Safety
de Paula, D. C. C., Leite, E. A., Araújo, C. M., Branquinho, R. T., Guimarães, H. N., & Grabe‐Guimarães, A. (2020) · Cardiovascular Toxicology · doi:10.1007/s12012-020-09599-x · Cited by 6
Recent changes in candidemia trends in a tertiary hospital (2011–2018)
Piqueras, A. I., Rubio, T. T., Medina, E. M. L., Gimeno, A., Modesto, V., Cantón, E., & Pemán, J. (2020) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2020.09.005 · Cited by 6
The Metabolism of Susceptibility: Clearing the FoG Between Tolerance and Resistance in Candida albicans
Druseikis, M. E., Mottola, A., & Berman, J. G. (2023) · Current Clinical Microbiology Reports · doi:10.1007/s40588-023-00189-3 · Cited by 5
Comparison of risk factors and mortality of candidemia by Candida auris versus Candida non -auris in intensive care units
Arslan, E., Turan, D., Karaşahin, Ö., Çaydaşı, Ö., Olçar, Y., Tekin, M. D., Adıyeke, E., Karadağ, F. Y., & Öztürk-Engin, D. (2025) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2025.2546482 · Cited by 5
BIOFILM FORMING CAPABILITY AND ANTIFUNGAL SUSCEPTIBILITY PROFILE OF Candida spp. FROM BLOOD
Costa, C. R., Marreto, L. C. N. L., Rocha, V. L., da Silva, T. C., & Silva, M. D. R. R. (2018) · Revista de Patologia Tropical / Journal of Tropical Pathology · doi:10.5216/rpt.v47i1.52351 · Cited by 5
A Novel Use for an Old Drug: Resistance Reversal in Candida Albicans by Combining Dihydroartemisinin with Fluconazole
Li, H., Chen, H., Shi, W., Shi, J., Yuan, J., Duan, C., Fan, Q., & Liu, Y. (2021) · Future Microbiology · doi:10.2217/fmb-2020-0148 · Cited by 5
Antifungal therapies in murine infections by Candida kefyr
Sanchis, M., Martín‐Vicente, A., Capilla, J., & Guarro, J. (2016) · Mycoses · doi:10.1111/myc.12468 · Cited by 5
Antifungal Susceptibility Testing of Dermatophytes
Wiederhold, N. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-67421-2_19 · Cited by 5
Chemical composition and antifungal activities of aromatic water of Zataria multiflora Boiss
Monfared, A. A., Yazdanpanah, M., Zareshahrabadi, Z., Pakshir, K., Ghahartars, M., Mehrabani, D., Yazdanpanah, S., Iraji, A., & Zomorodian, K. (2021) · Current Medical Mycology · doi:10.18502/cmm.7.3.7255 · Cited by 5
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of Candida albicans
Yu, P. K., Espiritu, L. M., & Lao, A. R. (2022) · mSystems · doi:10.1128/msystems.00691-22 · Cited by 5
Prosthetic valve endocarditis caused by multidrug-resistant Candida albicans in a patient with myelodysplasia syndrome: A case report and literature review
Kermani, F., Shokohi, T., Abastabar, M., Davoodi, L., Tabari, S. Z., Jalalian, R., Mehdipour, S., & Mirzakhani, R. (2018) · Current Medical Mycology · doi:10.18502/cmm.4.3.171 · Cited by 5
What Is the Target? Clinical Mycology and Diagnostics
Willinger, B. (2018) · Springer eBooks · doi:10.1007/978-3-319-92300-0_1 · Cited by 5
Comparisons of the clinical and mycological characteristics of pediatric candidemia
Chen, W.-C., Chen, P., Yang, S.-C., Yen, T., Lu, C., Chen, J., Lee, P., Chang, L., Chen, Y., & Huang, L. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.11.009 · Cited by 5
Distribution of Candida Species and Molecular Typing of C. albicans Isolates in a Mexico City Tertiary Care Hospital from 2011 to 2013
Guerrero, H. T., Israel Martínez, E., Ibarra, M. G., & García, M. A. (2016) · Open Journal of Medical Microbiology · doi:10.4236/ojmm.2016.62010 · Cited by 5
Caspofungin-Non-Susceptible Candida orthopsilosis Isolated from Onychomycosis in Iran.
Mohammadi, R., Mirhendi, H., Hedayati, M. T., & Badali, H. (2017) · PubMed Central · Cited by 5
Commercial Methods for Identification and Susceptibility Testing of Fungi
Moser, S. A., & Wicker, J. A. (2016) · Wiley eBooks · doi:10.1002/9781119021872.ch13 · Cited by 5
Nicotianin-I: A Tobacco Floral Nectar Peptide with Anticandidal Activity
Neto, J. M. D. M., Aguiar, T. K. B., Oliveira, M. F., Chaves, Q. L. S. G., Mourão, D. R. A. L., Silva, V. O., Nascimento, M. T. V., Carneiro, R. F., Martins, R. X., Farias, D. F., et al. (2025) · ACS Omega · doi:10.1021/acsomega.4c10806 · Cited by 4
Green-synthesized silver nanoparticles from black elderberry extract as potential TMPRSS2 inhibitors: Implications for SARS-CoV-2 antiviral therapeutics
Tavukçuoğlu, Ö., Çiftçi, F., Duygulu, N. E., Misirli, D., Elmastaş, M., & Işıldak, İ. (2025) · Materials Today Communications · doi:10.1016/j.mtcomm.2025.113609 · Cited by 4
Shifting Epidemiology and Antifungal Susceptibility Patterns of Clinical Fungal Isolates in an Intensive Care Unit (ICU) from Bucharest, Romania: A Retrospective Observational Study
Preda, M., Mahler, B., Popescu, O., Diţu, L.-M., Gheorghe-Barbu, I., Chivu, L. I., & Manolescu, L. S. C. (2026) · Antibiotics · doi:10.3390/antibiotics15050440 · Cited by 4
Fungal keratitis: Does antifungal Resistance Influence the outcome?
Vishwakarma, P., Gowtham, L., Sheba, E., Joseph, J., & Bagga, B. (2025) · International Ophthalmology · doi:10.1007/s10792-025-03847-1 · Cited by 4
Evaluation of the correlation of caspofungin MICs and treatment outcome in murine infections by wild type strains of Candida parapsilosis
Salas, V., Pastor, F. J., Capilla, J., Sutton, D. A., Mayayo, E., Fothergill, A. W., Rinaldi, M. G., & Guarro, J. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.05.011 · Cited by 4
Drug Resistance in Cryptococcosis
Hanson, K. E., Catania, J., Alexander, B. D., & Perfect, J. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_20 · Cited by 4
Virulence factors, antifungal susceptibility and molecular profile in Candida species isolated from the hands of health professionals before and after cleaning with 70% ethyl alcohol-based gel
Alves, P. G. V., Menezes, R. D. P., Silva, N. B. S., Faria, G. D. O., Bessa, M. A. D. S., de Araújo, L. B., de Aguiar, P. A. D. F., Penatti, M. P. A., Pedroso, R. D. S., & Röder, D. V. D. D. B. (2024) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2024.101482 · Cited by 4
Su Ürünleri Yetiştiriciliğinde Antibiyotik Direnci Riski: Geleceğe Bakış
Abarike, E. D., Okoampah, E., & Yılmaz, E. (2024) · Acta Aquatica Turcica · doi:10.22392/actaquatr.1478517 · Cited by 4
Silver secnidazole nano‐hybrid emulsion‐based probiotics as a novel antifungal formula against multidrug‐resistant vaginal pathogens
Mosallam, F. M., Helmy, E. A. M., El‐Bastawisy, H. S., & El-Batal, A. I. (2024) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2663 · Cited by 4
Comparing the frequency, antifungal susceptibility, and enzymatic profiles of the oral fungal composition in patients with and without Alzheimer's disease admitted to a neurology clinic
Golipoor, M., Rafat, Z., Saberi, A., Roostaei, D., & Shabanpour, A.-M. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1477230 · Cited by 4
Fabrication of a sponge-like protein based hydrogel incorporating fluconazole against Candida species as a potential treatment for vulvovaginal candidiasis infection
Hashempur, M. H., Radmanesh, A., Karami, F., Zomorodian, K., Amirzadeh, N., Shenavari, S., & Zareshahrabadi, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-09457-2 · Cited by 5
Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture
Cılo, B. D. (2023) · Cureus · doi:10.7759/cureus.38183 · Cited by 4
Multidrug- and Cross-Resistant Candida: the Looming Threat
Lackner, M., Martín‐Vicente, A., & Lass‐Flörl, C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0210-1 · Cited by 4
Correlation between broth microdilution, E-test and disk diffusion methods for testing antifungal susceptibility of Candida species isolated from Thai blood samples
Jaruvongvanich, V., Worasilchai, N., Kongnatthasate, K., Jaruvongvanich, S., Damkerngsuntorn, W., Atikarnbodee, D., Thammahong, A., Lerdlitruangsin, S., & Chindamporn, A. (2016) · Asian Biomedicine · doi:10.5372/1905-7415.1001.468 · Cited by 4
Clinical characteristics and risk factors for death in patients with Candida bloodstream infection in Intensive Care Unit.
Chen, X., Yang, Y., Li, Y., & Chen, J. (2021) · PubMed Central · doi:10.11817/j.issn.1672-7347.2021.201012 · Cited by 4
Candida bloodstream infection: A clinical microbiology laboratory perspective
Pongrácz, J., & Kristóf, K. (2014) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.61.2014.3.11 · Cited by 4
Candida species isolated from urine specimens and antifungal susceptibility in hospitalized patients
Atalay, M. A., Koç, A. N., Sav, H., & Demir, G. (2013) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2013.30633 · Cited by 4
Candidemia in Cancer Patients: Focus Mainly on Hematological Malignancyand Hematopoietic Stem Cell Transplantation
Okinaka, K. (2016) · Medical Mycology Journal · doi:10.3314/mmj.16.003 · Cited by 4
Çocuklarda Mikafungin Kullanımının Değerlendirilmesi
Yeşil, E., Çelebi, S., Evim, M. S., Özer, A., Turan, C. A., Timur, D., Çakır, S. Ç., Bülbül, B., Ener, B., Güneş, A. M., et al. (2020) · Mikrobiyoloji Bulteni · doi:10.5578/mb.68832 · Cited by 4
Antimicrobial Action of Nocardia vaccinii IMV B-7405 Surfactants
Pirog, T., (Покора), К. А. Б., Savenko, I. V., Shevchuk, Т. А., & Iutynska, G. O. (2015) · Mikrobiolohichnyi Zhurnal · doi:10.15407/microbiolj77.06 · Cited by 4
Biomimetic nanomicelles: utilizing peptide transporters to overcome corneal barrier for treating fungal infection
Sathe, P., Nagarjuna, V., Sharma, H., Velpandian, T., Garg, P., & Nirmal, J. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00423 · Cited by 3
Gradient concentration strip–specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes
Mercier, V., Letscher‐Bru, V., Bougnoux, M., Delhaès, L., Botterel, F., Maubon, D., Dalle, F., Alanio, A., Houzé, S., Dannaoui, É., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.11.030 · Cited by 3
Rapid Tetra-Primer Amplification Refractory Mutation System-Polymerase Chain Reaction Protocol for Detection of Y132F Mutation in Fluconazole Resistant Candida parapsilosis
Öztürk, S., Çam, K., Babuççu, G., Onem, U. A., Aydın, S., Kuşkucu, M. A., & Doğan, Ö. (2024) · Microbial Drug Resistance · doi:10.1089/mdr.2023.0198 · Cited by 3
Hospitalized COVID-19 Patients with Urinary Tract Infection in Iran: Candida Species Distribution and Antifungal Susceptibility Patterns
Shiyadeh, Z. S., Farahyar, S., Larijani, L. V., Beardsley, J., Nouri, N., Mahmoudi, S., Mohammadi, S. R., Rodrigues, C. F., & Roudbary, M. (2024) · Antibiotics · doi:10.3390/antibiotics13070633 · Cited by 3
Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome
Paredes, K., Pastor, F. J., Capilla, J., Sutton, D. A., Mayayo, E., Fothergill, A. W., & Guarro, J. (2014) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.10.008 · Cited by 3
One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?
Turan, D., & Aksaray, S. (2022) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20229709 · Cited by 3
Impact of the Disk Diffusion Test on Fluconazole De-Escalation in Patients with Candidemia
Tantasuwan, S., Chongtrakool, P., Waesamaae, A., & Chayakulkeeree, M. (2022) · Journal of Fungi · doi:10.3390/jof8111185 · Cited by 3
Increase in Antifungal Resistance Due to Variability in Candida Species: Experience from the Central Mycology Laboratory
Turan, D. (2023) · Haydarpaşa Numune medical journal (Online) · doi:10.14744/hnhj.2023.24572 · Cited by 3
Clinical characteristics and outcomes of colonization and infection by yeast species in solid organ transplant recipients: Molecular identification and antifungal susceptibility patterns of isolates
Yazdanpanah, S., Shafiekhani, M., Ahmadi, M., Zare, Z., Nikoupour, H., Arabsheybani, S., Geramizadeh, B., Anbardar, M. H., Chamanpara, P., Badali, H., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae118 · Cited by 4
In vitro activity of echinocandins against 562 clinical yeast isolates from a Romanian multicentre study
Mareș, M., Minea, B., Năstasă, V., Roșca, I., Bostănaru, A.-C., Marincu, I., Toma, V., Cristea, V. C., Murariu, C., & Pinteală, M. (2017) · Medical Mycology · doi:10.1093/mmy/myx059 · Cited by 3
Screening the in vitro susceptibility of posaconazole in clinical isolates of Candida spp. and Aspergillus spp. and analyzing the sequence of ERG11 or CYP51A in non-wild-type isolates from China
Zhang, H., Tan, J., Kontoyiannis, D. P., Zhou, Y., Liu, W., Zhu, P., Shi, X., Wan, Z., Li, R., & Liu, W. Y. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.05.003 · Cited by 3
Candidemia due to Non-Albicans Candida Species: Risk Factors, Species Distribution and Antifungal Susceptibility Profile
Deorukhkar, S. C., Roushani, S. B., & Bhalerao, D. S. (2017) · Cited by 3
Antimicrobial Resistance and Antimicrobial Nanomaterials
Saravanan, M., Belete, M. A., Niguse, S., Tsegay, E., Araya, T., Hadush, B., Mekonnen, K. N., & Periakaruppan, P. (2021) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-7998-5049-6.ch001 · Cited by 3
Antifungal Drug Efficacy Profiles Against Vaginal Candida albicans: A Multi-Drug Comparative Analysis
Zubair, M., & Albalawi, Y. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207266 · Cited by 2
Trends in Pediatric Invasive Candidiasis: Shifting Species Distribution and Improving Outcomes
Aykaç, K., Anac, E. G., Seyrek, B. E., Karaman, A., Demir, O. O., Ünalan-Altıntop, T., Gülmez, D., Arıkan-Akdağlı, S., Avci, H., Cengiz, A. B., et al. (2025) · Mycopathologia · doi:10.1007/s11046-025-01022-9 · Cited by 2
Genotyping of Candida albicans Isolates Obtained from Vulvovaginal Candidiasis Patients from Zanjan, Iran, Based on ABC and RPS Typing Systems
Amanloo, S., Zanjani, M., Serajian, S., Ahmadi, F., & kakavand, F. (2022) · Current Medical Mycology · doi:10.32598/cmm.2023.1364 · Cited by 2

Authors: Pfaller, M. A., & Diekema, D. J.
Affiliations: University of Iowa (US)
ORCID: Pfaller, M. A.
Diekema, D. J.
Venue: Journal of Clinical Microbiology
Publisher: American Society for Microbiology
Published: 2012-09
Volume: 50
Issue: 9
Pages: 2846-2856
ISSN: 0095-1137 (ISSN-L)
1098-660X
DOI: 10.1128/jcm.00937-12
PMC: PMC3421803
OpenAlex: W2120299440
Cited by: 484
References: 105
Citations by year: 2026: 15 · 2025: 20 · 2024: 24 · 2023: 29 · 2022: 26 · 2021: 41 · 2020: 41 · 2019: 31 · 2018: 43 · 2017: 46 · 2016: 45 · 2015: 41 · 2014: 47 · 2013: 31 · 2012: 4
FWCI: 4.88
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Clinical Microbiology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Pfizer
Eisai
Astellas Pharma
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
Keywords: Candida, antifungal susceptibility testing, broth microdilution, epidemiological cut-off values, clinical breakpoints, fluconazole, voriconazole, echinocandins, antifungal resistance, Candida species, CLSI guidelines
MeSH terms: Antifungal Agents, Candida, Candidiasis, Humans, Microbial Sensitivity Tests

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks